In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth
Author:
Affiliation:
1. Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA
2. Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut, USA
Abstract
Funder
HHS | U.S. Food and Drug Administration
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/aac.02167-21
Reference34 articles.
1. The Burden of Bloodstream Infections due to Stenotrophomonas Maltophilia in the United States: A Large, Retrospective Database Study
2. Advances in the Microbiology of Stenotrophomonas maltophilia
3. Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria
4. Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
5. Clinical and Laboratory Standards Institute. 2021. Performance standards for antimicrobial susceptibility testing, 31st ed, CLSI supplement M100. Clinical and Laboratory Standards Institute, Wayne, PA.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Long Story Short: Establishing Breakpoints for Antimicrobials and 2023 Updates;Current Infectious Disease Reports;2024-01-18
2. Treatment approaches for severe Stenotrophomonas maltophilia infections;Current Opinion in Infectious Diseases;2023-10-16
3. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections;Clinical Infectious Diseases;2023-07-18
4. Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-06-08
5. Trimethoprim/sulfamethoxazole pharmacodynamics against Stenotrophomonas maltophilia in the in vitro chemostat model;Journal of Antimicrobial Chemotherapy;2022-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3